Steroids in sepsis: Another swing of the pendulum in our clinical trials

Critical Care

Volumn 12, Issue 2, 2008, Pages

  Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; SODIUM CHLORIDE;

ADRENAL INSUFFICIENCY; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE UNIT; LOW DRUG DOSE; METHODOLOGY; MORTALITY; NOTE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; ARTICLE;

ADRENAL CORTEX HORMONES; CLINICAL TRIALS AS TOPIC; HUMANS; RESEARCH DESIGN; SEPSIS;

EID: 42949137026     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6861     Document Type: Note

References (14)

1. Schumer W Steroids in the treatment of clinical septic shock Ann Surg 1976, 184:333-341. 1344393 786190 10.1097/00000658-197609000-00011
2. Bone RC Fisher CJJ Clemmer TP Slotman GJ Metz CA Balk RA A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 1987, 317:653-658. 3306374
3. Veterans Administration Systemic Sepsis Cooperative Study Group Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis N Engl J Med 1987, 317:659-665. 2888017
4. Lefering R Neugebauer EA Steroid controversy in sepsis and septic shock: a meta-analysis Crit Care Med 1995, 23:1294-1303. 10.1097/ 00003246-199507000-00021 7600840
5. Cronin L Cook DJ Carlet J Heyland DK King D Lansang MA Fisher CJ Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature Crit Care Med 1995, 23:1430-1439. 10.1097/00003246-199508000-00019 7634816
6. Annane D Bellissant E Sebille V Lesieur O Mathieu B Raphael JC Gajdos P Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve Br J Clin Pharmacol 1998, 46:589-597. 1873798 9862249 10.1046/j.1365-2125.1998.00833.x
7. Bollaert PE Charpentier C Levy B Debouverie M Audibert G Larcan A Reversal of late septic shock with supraphysiologic doses of hydrocortisone Crit Care Med 1998, 26:645-650. 10.1097/ 00003246-199804000-00010 9559600
8. Briegel J Forst H Haller M Schelling G Kilger E Kuprat G Hemmer B Hummel T Lenhart A Heyduck M Stoll C Peter K Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study Crit Care Med 1999, 27:723-732. 10.1097/00003246-199904000-00025 10321661
9. Annane D Sebille V Charpentier C Bollaert PE Francois B Korach JM Capellier G Cohen Y Azoulay E Troché G Chaumet-Riffaut P Bellissant E Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 2002, 288:862-871. 10.1001/jama.288.7.862 12186604
10. Dellinger RP Carlet JM Masur H Gerlach H Calandra T Cohen J Gea-Banacloche J Keh D Marshall JC Parker MM Ramsay G Zimmerman JL Vincent JL Levy MM Surviving sepsis campaign guidelines for management of severe sepsis and septic shock Crit Care Med 2004, 32:858-873. 10.1097/01.CCM.0000117317.18092.E4 15090974
11. Sprung CL Annane D Keh D Moreno R Singer M Freivogel K Weiss YG Benbenishty J Kalenka A Forst H Laterre PF Rein-hart K Cuthbertson BH Payen D Briegel J Hydrocortisone therapy for patients with septic shock N Engl J Med 2008, 358:111-124. 10.1056/NEJMoa071366 18184957
12. Finfer S Corticosteroids in septic shock N Engl J Med 2008, 358:188-190. 10.1056/NEJMe0708098 18184965
13. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Fisher CJ Jr Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001 11236773
14. Abraham E Laterre PF Garg R Levy H Talwar D Trzaskoma BL François B Guy JS Brückmann M Rea-Neto A Rossaint R Per-rotin D Sablotzki A Arkins N Utterback BG Macias WL Drotrecogin alfa [activated] for adults with severe sepsis and a low risk of death N Engl J Med 2005, 353:1332-1341. 10.1056/NEJMoa050935 16192478